The HVP90 inhibitor NVPAUY922 and the PI3K-mTOR inhibitor NVP-BEZ235, alone or in combination, have a significant effect on the apoptosis of cholangiocarcinoma cells; and these inhibitors act on the rat model of cholangiocarcinoma to decrease the tumor (67). The gene discussed is MTOR; the disease is cholangiocarcinoma.